FRCEM SBA practice questions is a core part of UK Emergency Medicine practice. The ability to locate a clinical question within the evidence hierarchy is not merely an academic exercise confined to research departments. In the UK emergency department, it determines whether a management decision rests on a solid meta-analytic foundation or on an anecdote from a case series published two decades ago. The Royal College of Emergency Medicine curriculum explicitly embeds evidence-based medicine (EBM) competencies across its syllabus, and the FRCEM examination tests them repeatedly through carefully constructed single best answer questions. Candidates who treat EBM as peripheral revision material do so at their peril: understanding how evidence is graded, how guidelines derive their recommendations, and how to apply this reasoning under exam conditions is a reliable source of marks. This article works through the conceptual framework, maps it to the FRCEM SBA exam, and equips you with the high-yield facts that separate confident candidates from those who guess.
FRCEM SBA practice questions: Key Points
- Evidence-based medicine integrates three equally weighted pillars: best available evidence, clinical expertise, and patient values. The exam tests all three, not just research methodology.
- The evidence hierarchy arranges study designs by capacity to minimise bias. Systematic reviews and meta-analyses of RCTs occupy the apex; expert opinion and case reports sit at the base.
- NICE and RCEM guidelines explicitly grade their recommendations (typically A to D or equivalent) based on the underlying level of evidence. Knowing which grade applies to a given intervention is directly examinable.
- The 5-step EBM process (Ask, Acquire, Appraise, Apply, Assess) and the PICO framework are high-yield for question stems that present a clinical scenario followed by a methodology question.
- Common exam traps include conflating statistical significance with clinical significance, confusing relative risk reduction with absolute risk reduction, and misidentifying study design from a brief description.
- Allergy and angioedema topics (including hereditary angioedema, anaphylactoid reactions, and urticaria) appear regularly in FRCEM SBA clinical scenarios and are underpinned by evidence at varying hierarchical levels, making them ideal vehicles for testing EBM application.
Foundations of Evidence-Based Medicine in the Emergency Department
The canonical definition, articulated by Sackett and colleagues in the BMJ, describes EBM as the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients. The word judicious is doing considerable work in that definition. It signals that evidence is not applied mechanically: a meta-analysis reporting a population-level effect must be filtered through the clinician’s assessment of whether the trial population resembles the patient in resus bay four, and through that patient’s own values and circumstances.
The three pillars of EBM are best understood as equally necessary rather than hierarchical. Best available evidence without clinical expertise produces algorithmic care that fails atypical presentations. Clinical expertise without evidence produces confidence untethered from data. Neither functions without attending to patient values, the principle that underpins shared decision-making and that the GMC reinforces in its professional standards. In the ED context, an elderly patient with submassive pulmonary embolism requires a thrombolysis conversation that draws on all three pillars simultaneously: trial data on outcomes, the clinician’s read of haemodynamic trajectory, and the patient’s or surrogate’s priorities.
The structured approach to applying EBM is conventionally described as five steps, often recalled as the 5As: Ask (formulate a structured PICO question), Acquire (search PubMed, Cochrane, NICE Evidence), Appraise (critically evaluate validity and applicability), Apply (integrate evidence with expertise and patient context), and Assess (evaluate outcome and contribute to audit). FRCEM SBA practice questions frequently anchor a methodology stem to a clinical scenario, requiring candidates to identify which step is being described or which tool is most appropriate at a given stage.
The PICO Framework: Worked Example from the ED
The PICO framework structures the Ask step and is directly examinable. Consider this scenario, representative of the kind of stem you will encounter in FRCEM SBA exam questions: a consultant wants to know whether a 0-hour/1-hour high-sensitivity troponin protocol reduces unnecessary admissions in adult ED patients with low-risk chest pain compared with standard 3-hour sampling.
Breaking this into PICO: Population is adult ED patients with low-risk chest pain; Intervention is the 0h/1h high-sensitivity troponin protocol; Comparison is standard 3-hour troponin sampling; Outcome is rate of unnecessary admission (or equivalently, time-to-safe-discharge). An SBA question might then ask which study design would provide the highest level of evidence to answer this question, or which existing evidence type the current NICE guidance on chest pain pathways is based upon. The answer in both cases requires fluency with the hierarchy.
The Evidence Hierarchy: Structure, Design, and Limitations
The evidence hierarchy arranges study designs by their ability to minimise bias and confounding. Understanding the architecture of the hierarchy, rather than memorising a single table, allows candidates to reason through novel question stems.
Level 1: Systematic Reviews and Meta-Analyses of RCTs
At the apex sit systematic reviews and meta-analyses that pool data from multiple well-conducted randomised controlled trials. These provide the highest precision estimates of treatment effects and, when adequately powered, can detect clinically important differences that individual trials cannot. The Cochrane Collaboration, accessible through NICE Evidence, is the primary repository. Limitations include heterogeneity between included studies, publication bias (positive trials are more likely to be published), and the risk that pooling methodologically inconsistent trials produces a misleading summary estimate. For the exam, recognise that a meta-analysis is only as robust as the trials it contains: garbage in, garbage out.
Level 2: Individual Randomised Controlled Trials
The RCT remains the gold standard for evaluating interventions. Randomisation, when adequately concealed and with sufficient power, controls for both known and unknown confounders. In emergency medicine, RCTs are logistically challenging: consent under time pressure, heterogeneous populations, and the ethical difficulty of withholding potentially life-saving treatment all create obstacles. Many ED interventions therefore rest on lower-level evidence than equivalent elective interventions, a fact the exam exploits. Candidates should be able to identify allocation concealment, blinding, and intention-to-treat analysis as the key quality markers of an RCT.
Level 3: Cohort Studies and Case-Control Studies
Observational study designs occupy the middle of the hierarchy. Prospective cohort studies follow exposed and unexposed groups forward in time, making them suitable for examining prognosis and harm. Case-control studies work backwards from outcome to exposure, making them efficient for rare diseases but susceptible to recall bias and selection bias. Neither design permits causal inference with the confidence of an RCT, but both generate the majority of the literature on which ED prognostic tools (TIMI, HEART score, PERC rule) are built.
Level 4: Cross-Sectional Studies and Case Series
Cross-sectional studies provide prevalence data at a single time point. They cannot establish temporal sequence and therefore cannot establish causation. Case series describe clinical features across a group of patients without a control population. They are hypothesis-generating rather than hypothesis-testing and appear frequently in the early literature on novel presentations, including the initial descriptions of anaphylactoid reactions and hereditary angioedema phenotypes.
Level 5: Expert Opinion and Mechanistic Reasoning
Expert opinion and consensus statements based on pathophysiological reasoning sit at the base of the hierarchy. They remain clinically important, particularly where RCT evidence is absent or unethical to generate (emergency treatment of hereditary angioedema, for example). The Resuscitation Council UK anaphylaxis guidelines acknowledge this explicitly, noting that several recommendations derive from expert consensus rather than RCT data, given the ethical and practical barriers to placebo-controlled trials in anaphylaxis.
Grading Recommendations: NICE and RCEM Frameworks
The evidence hierarchy informs, but does not mechanically determine, guideline recommendation grades. NICE uses a system in which recommendations are graded according to both the level of evidence and the direction and magnitude of effect. A strong recommendation (grade A) requires consistent evidence from well-conducted RCTs or systematic reviews. A grade D recommendation may reflect expert opinion or extrapolation from indirect evidence. RCEM clinical guidelines similarly assign levels of evidence and grades of recommendation, and FRCEM SBA exam questions regularly present a guideline statement and ask candidates to identify the most appropriate evidence grade.
A clinically important nuance: a grade D recommendation in a NICE or RCEM guideline does not mean the recommendation is wrong. It means the evidence base is limited. In emergency medicine, acting on the best available lower-quality evidence is frequently the only ethical option. The exam tests whether candidates understand this distinction.
How the FRCEM SBA Exam Tests the Evidence Hierarchy
The FRCEM SBA examination, governed by the RCEM curriculum, tests EBM knowledge both in standalone methodology questions and embedded within clinical scenario stems. Candidates working through FRCEM SBA practice questions will encounter several recurring patterns.
First, study design identification: a brief description of a research methodology is provided and candidates must select the correct design from five options. The discriminators are typically the presence or absence of randomisation, the direction of time (prospective versus retrospective), and whether a control group exists. Second, critical appraisal metrics: candidates are given numerical data (event rates, confidence intervals, p-values) and asked to calculate or interpret number needed to treat, absolute risk reduction, or relative risk reduction. Third, guideline interpretation: a management recommendation is presented alongside its evidence grade, and candidates must identify whether the grade is consistent with the described evidence base. Fourth, PICO construction: a clinical question is described in plain language and candidates must identify the correctly structured PICO formulation from five options.
The allergy and angioedema module provides a rich source of these question types. Anaphylaxis management (adrenaline, antihistamines, corticosteroids), acute urticaria treatment, and the specific management of hereditary angioedema with C1-esterase inhibitor concentrate or icatibant all involve recommendations that derive from different levels of the hierarchy. A candidate who understands that the evidence for intramuscular adrenaline in anaphylaxis is largely observational and expert consensus, while the evidence for avoiding ACE inhibitors in hereditary angioedema is mechanistically and observationally grounded, will answer related EBM questions more accurately than one who has simply memorised drug doses.
Revision Pearls: High-Yield Facts for the FRCEM SBA
- The three pillars of EBM are best available evidence, clinical expertise, and patient values. All three are equally necessary; omitting any one distorts clinical decision-making.
- Systematic reviews reduce random error by pooling data, but they cannot eliminate the biases present in the included primary studies. A systematic review of poorly conducted RCTs does not produce high-quality evidence.
- Intention-to-treat analysis preserves the benefits of randomisation by analysing participants in the group to which they were allocated, regardless of whether they completed the intervention. Per-protocol analysis introduces bias.
- Number needed to treat (NNT) is calculated as 1 divided by the absolute risk reduction. It is a more clinically intuitive measure of effect size than relative risk reduction and is less susceptible to misinterpretation.
- Publication bias inflates apparent treatment effects in meta-analyses. Funnel plot asymmetry is the standard graphical method for detecting it, though it requires a sufficient number of studies to be interpretable.
- NICE grades recommendations A through D (and Good Practice Points for recommendations based entirely on expert opinion where no research is practical). Knowing which grade applies to a first-line ED intervention is directly examinable.
- Hereditary angioedema, anaphylactoid reactions, and urticaria are topics listed in the FRCEM Single Best Answer syllabus where mechanistic understanding and guideline knowledge intersect with EBM hierarchy questions in the same stem.
- The CONSORT statement governs reporting standards for RCTs; the PRISMA statement governs systematic reviews. Recognising these acronyms in a question stem and understanding their purpose distinguishes well-prepared candidates.
Common Pitfalls: Where Candidates Lose Marks
- Confusing relative risk reduction (which can appear dramatic) with absolute risk reduction (which reflects the actual clinical benefit). An intervention that reduces a 0.2% event rate to 0.1% has a 50% relative risk reduction but an absolute risk reduction of only 0.1%.
- Assuming that statistical significance equates to clinical significance. A p-value below 0.05 confirms that an observed difference is unlikely to be due to chance; it says nothing about whether the difference is large enough to matter to patients.
- Misidentifying retrospective cohort studies as case-control studies. The key discriminator is the starting point: cohort studies start with exposure status; case-control studies start with outcome status.
- Overlooking the role of confidence intervals. A wide confidence interval spanning both benefit and harm is clinically important even if the point estimate favours intervention.
- Applying a trial’s findings to a population clearly excluded from the study. An RCT conducted in secondary care hospitals in North America may not be directly applicable to a UK district general ED population.
- Failing to recognise that a grade A recommendation requires consistent evidence from multiple well-conducted RCTs, not simply one positive trial.
How EM Learning Centre Supports Your FRCEM Single Best Answer Revision
Systematic, structured revision is what separates candidates who pass first time from those who sit the FRCEM SBA exam repeatedly. The FRCEM Single Best Answer revision course at EM Learning Centre is built around the RCEM curriculum, covering high-yield topics including evidence-based medicine, acute allergy, anaphylactoid reactions, angioedema (including hereditary angioedema), and urticaria, all presented at the academic depth the exam demands. Each lesson integrates clinical content with the methodological knowledge required to answer EBM-embedded question stems, mirroring the format of the actual examination.
Our FRCEM SBA practice questions are written by practising UK emergency medicine consultants and reviewed against current NICE guidance, RCEM guidelines, and the best available primary literature. Detailed explanations accompany every question, unpacking not just the correct answer but the reasoning process, the evidence base, and the common distractors, so that you understand the principle rather than memorising an isolated fact. Candidates preparing for the FRCEM SBA exam who want a structured, evidence-grounded question bank and lesson library will find everything they need at the EM Learning Centre homepage.
References
- Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312:71. The BMJ
- Royal College of Emergency Medicine. RCEM Curriculum and Credentialling Framework. Royal College of Emergency Medicine
- Resuscitation Council UK. Emergency Treatment of Anaphylaxis: Guidelines for Healthcare Providers. Resuscitation Council UK
- National Institute for Health and Care Excellence. Developing NICE Guidelines: The Manual. NICE
- Scottish Intercollegiate Guidelines Network. SIGN 50: A Guideline Developer’s Handbook. Scottish Intercollegiate Guidelines Network